Replies to post #90639 on Biotech Values

[genisi]

I think management said there were higher royalties payments on Copaxon to SNY.

[genisi]

There was likely inventory stocking before year-end price hike.

[genisi]

In some market, the question of timing of the tender really affects the sales in this quarter (Q4).

Moshe Manor at Teva's Q4 2009 Earnings Call.

http://seekingalpha.com/article/188830-teva-pharmaceutical-industries-limited-q4-2009-earnings-call-transcript?page=-1